Interventricular septal curvature as an additional echocardiographic parameter for evaluating chronic thromboembolic pulmonary hypertension: a single-center retrospective study
Noninvasive estimation of the actual systolic pulmonary artery pressure measured via right-sided heart catheterization (sPAPRHC) is vital for the management of pulmonary hypertension, including chronic thromboembolic pulmonary hypertension (CTEPH). Evaluation related to the interventricular septum (IVS) is generally performed with only visual assessment and has been rarely assessed quantitatively in the field of echocardiography. Thus, this study aimed to investigate the utility of echocardiographic IVS curvature to estimate sPAPRHC in patients with CTEPH.
Methods
Medical records of 72 patients with CTEPH were studied retrospectively. We estimated sPAPRHC using echocardiographic IVS curvature (esPAPcurv) and left ventricular eccentricity index (esPAPLVEI), and compared their ability to predict sPAPRHC with estimated sPAPRHC using tricuspid regurgitant pressure gradient (esPAPTRPG).
Results
IVS curvature and LVEI were significantly correlated with sPAPRHC (r = − 0.52 and r = 0.49, respectively). Moreover, the IVS curvature was effective in estimating the sPAPRHC of patients with trivial tricuspid regurgitation (r = − 0.56) and in determining patients with sPAPRHC ≥ 70 mmHg with higher sensitivity (77.0%) compared to those with esPAPTRPG and esPAPLVEI.
Conclusion
Our results indicate that the echocardiographic IVS curvature could be a useful additional tool for estimating sPAPRHC in CTEPH patients for whom accurate estimation of sPAPRHC using tricuspid regurgitant pressure gradient is challenging.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CTEPH
Chronic thromboembolic pulmonary hypertension
CT
Computed tomography
ESC/ERS
European Society of Cardiology/European Respiratory Society
ICC
Intraclass correlation coefficient
IVC
Inferior vena cava
IVS
Interventricular septum
LVEI
Left ventricular eccentricity index
MRI
Magnetic resonance imaging
PH
Pulmonary hypertension
RHC
Right-sided heart catheterization
esPAPcurv
SPAPRHC using echocardiographic IVS curvature
esPAPTRPG
SPAPRHC using tricuspid regurgitant pressure gradient
sPAPRHC
Systolic pulmonary artery pressure measured via right-sided heart catheterization
TRPG
Tricuspid regurgitant pressure gradient
TR
Tricuspid regurgitation
Introduction
Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by untreated thromboembolism of the pulmonary arteries, leading to right ventricular afterload, progression of pulmonary hypertension (PH), and life-threatening right heart failure [1]. Pulmonary artery pressure measurement using right-sided heart catheterization (RHC) is considered the gold standard for diagnosing PH, but RHC can be challenging because of the invasiveness of the procedure. Echocardiography is routinely used for patients with suspected or diagnosed PH to roughly check the severity of PH and determine if they need RHC to manage PH.
Tricuspid regurgitant pressure gradient (TRPG) measured using echocardiography is among highly reliable parameters in the noninvasive measures for predicting actual systolic pulmonary arterial pressure measured using RHC (sPAPRHC). Therefore, TRPG is widely used for estimating sPAPRHC in clinical practice. However, we sometimes encounter PH patients in whom the systolic pulmonary arterial pressure estimated using TRPG (esPAPTRPG) clearly differs from the sPAPRHC, resulting in critical management errors. One reason for this discrepancy (i.e., between esPAPTRPG and sPAPRHC) is that esPAPTRPG depends on the degree of the angle between the tricuspid regurgitation (TR) jet and Doppler beam [2]. Another possible reason is that some patients have too trivial TR to measure TR velocity, resulting in seemingly normal TRPG values. Previous studies have reported that esPAPTRPG might be significantly underestimated in some patients with severe PH because the modified Bernoulli equation cannot be used in such cases [3‐5]. Thus, esPAPTRPG cannot always be helpful in evaluating the severity of PH. Therefore, other echocardiographic components are required for better management of patients with unreliable TRPG.
Anzeige
The 2015 European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines suggested grading the probability of PH based not only on TRPG but also on additional prespecified echocardiographic variables including left ventricular eccentricity index (LVEI) which is one of the parameters used to quantify the flattening of the interventricular septum (IVS) [5]. The IVS curvature is also the parameter used to quantify IVS configuration. In the 1980s, King et al. [6] first showed moderately high correlation between the IVS curvature on echocardiography and right ventricular systolic pressure qualitatively in children with congenital cardiac disorders. Studies on cardiac computed tomography (CT) and magnetic resonance imaging (MRI) have shown that quantified values of the IVS curvature correlate well with sPAPRHC in patients with PH including CTEPH [7‐9]. In routine clinical echocardiography, most examiners check IVS displacement in addition to TRPG measurements to predict the severity of PH. However, evaluation related to the IVS is generally performed with visual assessment alone and has been rarely assessed quantitatively in echocardiography.
With the above background, this study aimed [1] to investigate the correlation between the echocardiographic IVS curvature and sPAPRHC in CTEPH patients and [2] to evaluate the diagnostic performance of the IVS curvature in patients in whom accurate estimation of sPAPRHC based on TRPG is difficult due to trivial TR and severe PH. We hypothesized that the IVS curvature could be a good echocardiographic parameter in addition to TRPG for evaluating sPAPRHC in CTEPH patients especially with unreliable TRPG.
Methods
Study subjects
This single-center retrospective study was approved by the Institutional Review Board of Chiba University Graduate School of Medicine (First approval date: June 1, 2009; Update approval date: October 12, 2020. Approval number: 826). All of enrolled patients gave their consent to participate in our study. Registrations were consecutively conducted at each patient’s first diagnostic investigation at the PH Clinics in our hospital (if consent to participate in our study was given). Patients with arrhythmias (n = 5), history of pulmonary endarterectomy (n = 27), and other cases (n = 5) regarded as conditions affecting IVS motion were excluded. No patient had complex congenital heart disease, history of myocardial infarction, intracardiac shunt, left ventricular hypertrophy, more than mild left-sided valvular regurgitation, prosthetic valves, valvular stenosis, or wall-motion abnormalities. After excluding 37 patients, we enrolled 72 patients (59.7 ± 1.5 years; 51 females) with proven CTEPH.
Clinical assessment
Diagnosis of CTEPH was established based on clinical guidelines valid at study initiation [10]. In brief, PH was confirmed with RHC indicating mean pulmonary artery pressure ≥ 25 mmHg at rest and pulmonary capillary wedge pressure ≤ 15 mmHg. CTEPH was defined as abnormalities on a ventilation–perfusion scan and pulmonary angiography. All patients received anticoagulants and underwent two-dimensional and Doppler echocardiography as well as RHC. The time between RHC and echocardiography was less than 48 h. No hemodynamic manipulation was performed, and no changes were made to medication or oxygen therapy in the interim.
Anzeige
RHC
A 7.5-F Swan-Ganz thermodilution catheter (Edwards Lifesciences LLC, Irvine, CA) was used, and a jugular approach was preferred. Pressure measurements were taken from the right atrium, right ventricle, and main pulmonary artery at end expiration. Cardiac output was determined using the thermodilution method averaging a minimum of three measurements. Left-to-right shunting was ruled out using oximetry. All invasive variables were recorded blinded to the echocardiography.
Echocardiography
Complete echocardiography and Doppler echocardiography evaluations were performed using a commercially available system (Aplio300, Toshiba, Japan) with a 2.5-MHz transducer, in multiple views with patients in the spine or left lateral decubitus position. All echocardiographic examinations were performed by one of the three senior pulmonologists (AM, AS, and HK with 3-, 8-, and 8-year subspecialty training, respectively, in echocardiography as a part of routine clinical practice). Doppler echocardiography was performed in multiple views to obtain the optimal TR jet. After acquiring necessary images, TR velocity was measured in real time, and esPAPTRPG was determined using the modified Bernoulli equation TRPG = 4 × (TR velocity)2, in conjunction with the echocardiographic estimation of the right atrial pressure. The estimated right atrial pressure was calculated based on the size and collapsibility of the inferior vena cava (IVC) and on the following established criteria. In brief, the estimated right atrial pressure was defined as 3 mmHg when the IVC diameter was ≤ 21 mm and collapsing > 50%; 8 mmHg when the IVC diameter was ≤ 21 mm and collapsing < 50% or IVC diameter > 21 mm and collapsing > 50%; and 15 mmHg when the IVC diameter was > 21 mm and collapsing < 50% [11].
Measurement of LVEI and IVS curvature
Imaging data were stored digitally for off-line analyses. The LVEI and IVS curvature were obtained from the same compiled off-line images, which were the standard parasternal short-axis plane of the left ventricle at end systole, defined as the frame with the smallest short axis. Based on a method for the measurement of the IVS curvature in a previous study using cardiac CT [7], we set the left ventricular papillary muscle level as suitable to obtain images for the LVEI and IVS curvature.
LVEI was measured as the ratio of the major axis of the left ventricle parallel to the septum (D2) divided by the minor axis perpendicular to the septum (D1) [3, 12]. The mathematical method used in this study to calculate the IVS curvature was the same as in other studies [7, 9, 13]. The IVS curvature was measured in views showing the endocardial surface of the left ventricle at the papillary muscle level at end systole. As shown in Fig. 1, three different points at the posterior (a), middle (b), and anterior (c) positions of the interventricular septum were marked, and the X and Y coordinates were recorded at these three points using ImageJ (https://imagej.nih.gov/ij/) (Fig. 1b, e). A circle that passed through the three points on the septum was used to calculate IVS curvature defined as the reciprocal of the radius. A rightward (physiologic) curvature was denoted as a positive value (Fig. 1c) and a leftward curvature as a negative value (Fig. 1f). Two examiners (AS and HK) blinded to the subjects’ identities provided all measurements.
Fig. 1
The method used to measure interventricular septal curvature. (a, d) Short-axis images of the heart at the level of left ventricular papillary muscles were acquired at end systole. (b, e) Three different points at the posterior (a: Xa, Ya), middle (b: Xb, Yb), and anterior (c: Xc, Yc) positions on the endocardial surface of the interventricular septum were marked. The X and Y coordinates were read. A circle that passed through the three points on the septum (circle shown partially) was used to calculate radius of curvature of the septum. (c) A rightward (physiologic) curvature was denoted as a positive value and (f) a leftward curvature as a negative value
×
Statistical analysis
All statistical analyses were performed using R version 3.5.1 (The R Foundation for Statistical Computing, Vienna, Austria). To assess inter-rater reliability, the intraclass correlation coefficient (ICC) [14] with a two-way random model was calculated. Pearson’s correlation was used to investigate the association of the IVS curvature and LVEI with sPAPRHC. To compare the trend of echo-derived measurements, the IVS curvature and LVEI were transformed into the sPAP scale using a linear regression model with sPAPRHC as the dependent variable. We evaluated the sensitivity and specificity of the echo-derived sPAP for predicting sPAPRHC ≥ 70 mmHg using a 2 × 2 table with the number of sPAPRHC ≥ 70 or < 70 and the number of the echo-derived sPAP ≥ 70 or < 70. A P value < 0.05 was considered statistically significant in all tests.
Results
Patient characteristics
The study group comprised 72 consecutive patients with confirmed CTEPH. Baseline characteristics, hemodynamic data, and echocardiographic parameters of the subjects are shown in Table 1.
Table 1
Baseline characteristics of subjects
All (n = 72)
Age (years)
59.7 ± 1.5
Sex, n (M/F)
21/51
Body surface area (m2)
1.62 ± 0.02
Pulmonary hemodynamic data
Mean PAP (mmHg)
40.1 ± 1.3
Systolic PAP (mmHg)
70.1 ± 2.4
Diastolic PAP (mmHg)
20.5 ± 0.8
PAWP (mmHg)
8.5 ± 3.6
PVR (Wood units)
8.2 ± 0.5
Cardiac output (L/min)
4.5 ± 0.1
Cardiac index (L min−1 m−2)
2.7 ± 0.1
Echocardiographic parameters
TR grade, n
Trivial
13
Mild
40
Moderate
11
Severe
6
TRPG (mmHg)
60.1 ± 2.6
TAPSE(mm)
19.6 ± 0.4
Data are represented as mean ± standard deviation or number
CTEPH chronic pulmonary thromboembolic hypertension, PAP pulmonary artery pressure, PVR pulmonary vascular resistance, RA right atrium, TAPSE tricuspid annular plane systolic excursion, TR tricuspid regurgitation, TRPG tricuspid regurgitation pressure gradient
Inter-rater reliability
The ICC between two raters for the IVS curvature and LVEI showed a moderate value of 0.60 and 0.84, respectively, indicating that the measurements had substantial to almost perfect reliability.
Relationships between sPAPRHC and echo-derived sPAPs
Patients with trivial TR (n = 13) were excluded from the correlation analysis because the trivial TR should be too small to be used for measuring accurate TR velocity. Figure 2a–c show linear regression plots and correlation coefficients for sPAPRHC and compared the three types of echo-derived parameters in 59 patients. Statistically significant negative or positive correlations were found between the sPAPRHC and esPAPTRPG (r = 0.63, P < 0.01; Fig. 2a), sPAPRHC and IVS curvature (r = − 0.52, P < 0.01; Fig. 2b) and sPAPRHC and LVEI (r = 0.49, P < 0.01; Fig. 2c).
Fig. 2
Correlation between actual systolic pulmonary artery pressure (sPAPRHC) and three echocardiography-derived parameters. (a) Correlation between sPAPRHC and systolic pulmonary artery pressure estimated using TRPG (sPAPTRPG). (b) Correlation between sPAPRHC and interventricular septal curvature (IVS curvature) (c) Correlation between sPAPRHC and left ventricular eccentricity index (LVEI)
×
Anzeige
Diagnostic performance of the IVS curvature
The IVS curvature and LVEI data were directly converted into the sPAP scale using a Linear regression model. The equations were developed using the data of all patients:
For investigating the agreement between sPAPRHC and echo-derived sPAPs, Bland–Altman plots were created to compare sPAPRHC and esPAPcurv, esPAPLVEI, and esPAPTRPG (Additional file 1: Fig. S1). Proportional biases between sPAPRHC and esPAPcurv (P = 0.01) and sPAPRHC and esPAPLVEI (P < 0.01) were found. No proportional bias was observed between esPAPRHC and esPAPTRPG (P = 0.18) and no fixed biases in esPAPcurv, esPAPLVEI, or esPAPTRPG (P = 1.00, 1.00, and 0.08, respectively) were found. The 95% limit of agreements from Bland–Altman analysis of esPAPcurv was lowest in echo-derived sPAP, suggesting that esPAPcurv has lower marginal error than esPAPLVEI and esPAPTRPG.
To ascertain whether the IVS curvature could estimate the sPAPRHC more accurately in patients with unreliable TRPG, we verified the diagnostic performance of the IVS curvature for patients with trivial TR and severe PH whose TRPG is regarded as unreliable.
We were not able to obtain TRPG in some patients with trivial TR because their TR flow could not be detected clearly. Therefore, we confirmed whether the IVS curvature and LVEI accurately estimate the sPAPRHC of patients with trivial TR and not compare them with esPAPTRPG. A statistically significant negative correlation was found between sPAPRHC and esPAPcurv (r = 0.56, P = 0.04; Fig. 3a), however there was no significant correlation between sPAPRHC and esPAPLVEI (r = 0.17, P = 0.63; Fig. 3b). These results indicate that the IVS curvature, not LVEI, would be useful to estimate sPAPRHC for patients with trivial TR.
Fig. 3
Correlation between actual systolic pulmonary artery pressure (sPAPRHC) and estimated sPAPs converted from IVS curvature and LVEI in patients with trivial TR. (a) Correlation between sPAPRHC and estimated PAP converted from IVS curvature. (b) Correlation between sPAPRHC and estimated PAP converted from LVEI
×
Anzeige
As mentioned above, the modified Bernoulli equation cannot be used in patients with severe PH, leading to the underestimation of esPAPTRPG. Therefore, we confirmed sensitivity and specificity in estimating sPAPRHC ≥ 70 mmHg for esPAPcurv, esPAPLVEI, and esPAPTRPG. As shown in Table 2, the sensitivity of esPAPcurv (77%) were better than those of esPAPLVEI (59%) and esPAPTRPG (69%). Additionally, the sensitivity of esPAPTRPG with esPAPcurv was much higher than esPAPTRPG alone. This indicates that the IVS curvature, not LVEI, would be a excellent additional tool of esPAPTRPG to avoid overlooking severe PH.
Table 2
Sensitivity and specificity in estimating sPAPRHC ≥ 70 mmHg for esPAPcurv,, esPAPLVEI, esPAPTRPG, and esPAPTRPG with esPAPcurv
esPAPcurv (%)
esPAPLVEI (%)
esPAPTRPG (%)
esPAPcurv + esPAPTRPG (%)
Sensitivity
77
59
69
89
Specificity
65
85
58
64
Discussion
To the best of our knowledge, this is the first study to assess the quantitative utility of the IVS curvature obtained using echocardiography for estimating sPAPRHC in patients with CTEPH.
The echocardiographic IVS curvature could compensate for the disadvantages of esPAPTRPG, especially in the management of patients with unreliable TRPG including trivial TR and severe PH.
In this study, the ICC for the IVS curvature and LVEI showed mild values (0.60 [0.41–0.74, 95% confidence interval] and 0.84 [0.75–0.90], respectively), suggesting that the IVS curvature measured using echocardiography could be as reliable as that measured using cardiac CT [7].
Anzeige
Correlations of the IVS curvature with sPAPRHC (r = − 0.55; Additional file 1: Fig. S1) in all CTEPH patients including them with trivial TR were less than those reported using CT [7] and MRI [15]. However, the echocardiographic IVS curvature should have the advantage of being a noninvasive, easy and low-cost tool unlike CT and MRI. From the viewpoint of safety, compared with MRI, it can be used for post-pulmonary endarterectomy patients with nontitanium wire. Moreover, the measurement of the echocardiographic IVS curvature can be performed easily using simple two-dimensional echocardiography without Doppler or three-dimensional echocardiography, unlike TRPG. This study excluded patients with insufficient TR jet for measuring TR velocity. Therefore, we suspected that the utility of the IVS curvature might be higher in the management of patients with CTEPH than predicted from this study.
Rich et al. [2] and Fisher et al. [16] both reported that the magnitude of pressure underestimation using esPAPTRPG was greater than overestimation, particularly at high sPAPRHC with fair or poor quality of Doppler TR jet. Mutlak et al. [4] reported that severe TR is related to higher sPAPRHC in general, but several patients with severe PH do not exhibit significant TR because of the remodeling of right heart cavities. Therefore, we focused on patients with trivial TR and severe PH regarded as unreliable TRPG and investigated the utility of the IVS curvature for estimating sPAPRHC.
In patients with trivial TR, a significant correlation was found between sPAPRHC and esPAPcurv statistically, indicating that the IVS curvature could estimate their sPAPRHC to some extent even if their sPAPRHC cannot be estimated due to trivial TR. Moreover, the sensitivity of esPAPcurv to predict patients with sPAPRHC ≥ 70 mmHg was better than those of esPAPTRPG and esPAPLVEI. The sensitivity and specificity of esPAPcurv for detecting patients with sPAPRHC ≥ 70 do not appear particularly high. However, the sensitivity of esPAPTRPG with esPAPcurv was much higher than esPAPTRPG alone. Echocardiographic results are often required to determine the need for RHC, and underestimation can therefore lead to a critical mistake, especially during the first visit. We assessed the utility of the IVS curvature as an additional tool to TRPG to better manage patients with unreliable TRPG, including trivial TR and severe PH.
The 2015 ESC/ERS guidelines regarded LVEI > 1.1 in systole and/or diastole as an additional prespecified echocardiographic variable to predict the probability of PH in symptomatic patients suspected of PH [5]. This study showed that the ICC of LVEI is higher than that of IVS curvature, indicating that LVEI have smaller interobserver error. However, as mentioned above, esPAPLVEI has no significant correlation with sPAPRHC in patients with trivial TR, and its sensitivity in estimating sPAPRHC ≥ 70 mmHg is lower than that of esPAPcurv. It indicates that the IVS curvature in CTEPH patients would be a more useful tool for estimating the probability and severity of PH than LVEI which are similar parameters for evaluating the flattening of IVS.
The IVS curvature was measured in views showing the endocardial surface of the left ventricle at the papillary muscle level at the end systole. However, it was challenging to show the papillary muscle clearly in some patients. To confirm if the accuracy of the IVS curvature depends on the transverse section imaged, we divided patients into two groups based on the presence of clearly visible or invisible left ventricular papillary muscles in echocardiographic images used for measuring IVS curvature. As shown in Additional file 1: Table S1, The visible group (n = 65) showed a significant correlation between sPAPRHC and IVS curvature (P < 0.0001, r = − 0.55). However, there was no significant correlation in the invisible group (n = 7, P = 0.17). The LVEI also showed the same result as the curvature (the visible group: P = 0.0002, r = 0.43; the invisible group: P = 0.11). This indicates that the accuracy of the IVS curvature and EI would depend on the transverse section imaged.
This study showed a linear relationship between the IVS curvature and sPAPRHC as Roeleveld et al. [13] reported in 379 adults suspected of PH and evaluated using MRI. However, the correlation value was lower in the present study (r = − 0.52, P < 0.01) than in their study (r = 0.77, P < 0.001). One possible reason for the lower correlation value in the present study is that echocardiographic IVS curvature might be dependent on patient’s physique and operator’s skill due to the use of local view in the heart instead of the whole heart in MRI. Another possible reason is that the present study included more patients with mild sPAPRHC < 50 mmHg than the study by Roeleveld et al., Lopez-Candales et al. showed that LVEI measured at conventional papillary muscle level showed the best correlation with sPAPRHC when the sPAPRHC ranged between 45 and 60 mm [17]. This indicates that the mechanical compliance of the IVS might be linear within a limited range of sPAPRHC.
This study has some limitations. First, it was a single-center retrospective study with a small number of patients. Multicenter studies with a larger number of subjects are needed to increase the generalizability of our findings. Second, we analyzed only CTEPH as a representative of conditions involving PH. To test the broad utility of the IVS curvature in PH management, further studies with several conditions involving PH need to be performed using the methods in this study.
Conclusions
The echocardiographic IVS curvature could be a reliable and promising parameter in addition to TRPG for estimating sPAPRHC in CTEPH and compensating for the disadvantages of esPAPTRPG, especially in the management of patients with unreliable TRPG, including trivial TR and severe PH.
Acknowledgements
We would like to thank Editage (www.editage.com) for English language editing.
Declarations
Ethics approval and consent to participate
The present study was a single-center retrospective investigation and was approved by the ethics committee of Chiba University (approved on June 1, 2009; approval number, 826). All patients provided informed consent.
Consent for publication
All study participants provided informed consent and the study design was approved by the appropriate ethics review board.
Competing interests
NT received a research grant from Nippon Shinyaku and honoraria from Actelion Pharmaceuticals, Nippon Shinyaku, Pfizer, Bristol-Myers Squibb, and Bayer. NT, AS, and TJ belong to the endowed department sponsored by Actelion Pharmaceuticals. Other authors have declared that no competing interests exist.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Interventricular septal curvature as an additional echocardiographic parameter for evaluating chronic thromboembolic pulmonary hypertension: a single-center retrospective study
Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.
Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.
Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.
Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
